Paradeep Phosphates Limited
Valuation (94/100) does the heavy lifting; quality (35/100) is the drag.
Buy zoneSolvency riskStocksWizard rates Paradeep Phosphates Limited a Sell, scoring 40/100 on our blended model. At ₹156.54 it trades below our blended DCF and relative-multiples fair value of ₹313.08, about 100% upside to that estimate — we read it as undervalued by 100%. On 14.2x trailing earnings it sits cheaper than the Chemicals median of about 41.0x. The price is about 32% below its 52-week high of ₹230.51 and 52% above the low of ₹103.19. Financial health scores 32/100, in the grey band on the Altman Z-score, with a Piotroski F-score of 4/9. The average analyst target of ₹146 implies about 7% downside across 3 analysts. It clears 6 of 13 investability checks, with durability 35, valuation 88 and momentum 72 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹250.46. Low-confidence estimate — limited data.
Analyst views
1-year price
EOD · 2026-07-2952-week range
-32.09% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell40Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 18.4%
- Fail: Low debt (D/E < 0.5): 1.02x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 35%
- Fail: Earnings growing: -24%
- Fail: Net margin ≥ 10%: 4.6%
- Fail: Current ratio > 1.5: 1.15
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 2.27
- Fail: Piotroski ≥ 7: 4/9
Quarterly results
Annual financials
Shareholding
- Promoter58.4%
- Institutions23.1%
- Public & other18.6%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Strong return on equity (18.4%).
Opportunities
- Revenue growing (35% YoY).
- Trading in our value buy zone versus sector peers.
- Trades ~100% below our estimated fair value.
Bear case
Threats
- Earnings contracting year on year.
About Paradeep Phosphates Limited
Paradeep Phosphates manufactures and distributes fertilizers and related chemical products in India, including urea, complex fertilizers, di-ammonium phosphate, NPK formulations, muriate of potash, triple super phosphate, and specialty products such as zypmite, phospho-gypsum, sulphuric acid, hydrofluorosilicic acid, ammonia, sulphur, and zinc. The company sells through dealers and retailers under the Navratna and Jai Kisaan brand names.
Paradeep Phosphates Limited — frequently asked questions
Is Paradeep Phosphates Limited a buy, hold or sell?
StocksWizard currently rates Paradeep Phosphates Limited (PARADEEP) a Sell, based on a blended score of 40/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Paradeep Phosphates Limited's fair value?
Our blended DCF and relative-valuation model estimates Paradeep Phosphates Limited's fair value at about ₹313.08, versus a current price of ₹156.54 — roughly 100% upside. On that basis the stock looks undervalued by 100%.
Is Paradeep Phosphates Limited financially healthy?
Paradeep Phosphates Limited scores 32/100 on our financial-health model, placing it in the grey band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has Paradeep Phosphates Limited's share price performed?
Paradeep Phosphates Limited is up 21% over three months, and last traded at ₹156.54. Past performance doesn't predict future returns.
More in Chemicals
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.